APA (7th ed.) Citation

Hui Shi, Peng Zhou, Ying-qun Ni, Shu-shu Wang, Rui Song, An-lu Shen, . . . Liang Wang. (2021). In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway. Elsevier.

Chicago Style (17th ed.) Citation

Hui Shi, Peng Zhou, Ying-qun Ni, Shu-shu Wang, Rui Song, An-lu Shen, Zhao-hui Fang, and Liang Wang. In Vivo and in Vitro Studies of Danzhi Jiangtang Capsules Against Diabetic Cardiomyopathy via TLR4/MyD88/NF-κB Signaling Pathway. Elsevier, 2021.

MLA (9th ed.) Citation

Hui Shi, et al. In Vivo and in Vitro Studies of Danzhi Jiangtang Capsules Against Diabetic Cardiomyopathy via TLR4/MyD88/NF-κB Signaling Pathway. Elsevier, 2021.